Skip to main content
. 2019 Jul 5;21:78. doi: 10.1186/s13058-019-1154-8

Fig. 3.

Fig. 3

Expression of PI3K/AKT/mTOR signaling pathway markers in paired baseline and on-treatment samples. a IRS score for pAKT S473, pS6 S235/236, pS6 S240/244, and Ki-67 in paired baseline and on-treatment samples. b Expression of PI3K/AKT/mTOR signaling pathway markers in the two patients who demonstrated clinical benefit. Upper panel, patient with partial response in PIK3CA cohort; bottom panel, patient with stable disease in PTEN cohort